The 9th World Congress on BA/BE Studies and Biowaivers 2017 is dedicated to discoveries, research and new therapeutic drugs on recent developments in field of generic drug research.
The 9th World Congress on BA/BE Studies and Biowaivers 2017 covers topics such as:
- Pharmacokinetics and Pharmacodynamics in Drugs
- Challenges in Drug Design and development
- Study Designs
- Clinical Research Vs Clinical Trails
- Need for conducting BA/BE Studies
- Factors affecting Bioavailability Studies
- Managing BA/BE Studies
- Bioequivalence Assessment
- Novel Drug Delivery Systems BA/BE approach
- Nutrient Bioavailability
- Recent approaches to Biosimilars
- Current Isuues on BA/BE determination
- Requirement of biowaivers
- BCS & IVIVC Based Biowaivers
- Contract Research Organizations
The 9th World Congress on BA/BE Studies and Biowaivers 2017 brings together senior attendees with job titles such as:
- Academic and Industrial Scientists Associated with Discovery, Formulation and The Delivery of Drugs
- CEOs, CROs, Directors, Managers and research associates in pharmaceutical industry in the drug or device industries (both innovator and generic)
- Researchers, Education providers In Clinical Pharmacy, Pharmacology and Toxicology
- Regulatory and Clinical Scientists Involved In Drug Development
- Government Agencies Involved In Chemical Safety Assessment
- Students and Postdoctoral Fellows In All Areas of The Pharmaceutical Sciences
- Molecular and Cellular Pharmacologists
- Medical Practitioners Such As Clinical Pharmacologists, Clinical Toxicologists
